April 30, 2019
OSU researcher gets $3.3 million grant to develop universal treatment for cystic fibrosis
A pharmaceutical sciences researcher at Oregon State University has received a five-year, $3.3 million grant from the National Institutes of Health to develop a way for cystic fibrosis patients to get molecular treatment via an inhaler, a potential vast improvement over existing therapeutic methods.